Projected Income Statement: CellaVision AB

Forecast Balance Sheet: CellaVision AB

Forecast Balance Sheet - CellaVision AB
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 6.37 -5.56 -56.9 -123 -163 -189 -230 -288
Change - -187.28% -923.38% -116.17% -32.52% -16.26% -21.69% -25.22%
Announcement Date 04/02/22 08/02/23 07/02/24 06/02/25 05/02/26 - - -
1SEK in Million
Estimates

Cash Flow Forecast: CellaVision AB

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 84.34 70.01 85.53 76.01 86.26 79.8 93.15 100.8
Change - -16.99% 22.16% -11.14% 13.48% -7.48% 16.73% 8.27%
Free Cash Flow (FCF) 1 114.2 67.27 110.9 122.4 114.3 109.8 121 144.1
Change - -41.09% 64.86% 10.39% -6.66% -3.89% 10.2% 19.09%
Announcement Date 04/02/22 08/02/23 07/02/24 06/02/25 05/02/26 - - -
1SEK in Million
Estimates

Forecast Financial Ratios: CellaVision AB

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 34.69% 31.03% 30.54% 30.24% 31.8% 29.11% 32.51% 33.45%
EBIT Margin (%) 28.77% 24.75% 24.66% 24.57% 26.62% 22.52% 25.96% 27.34%
EBT Margin (%) 27.99% 23.22% 24.25% 24.45% 25.6% 22.4% 25.74% 27.03%
Net margin (%) 22.16% 18.51% 19.24% 19.46% 20.17% 17.75% 20.64% 21.63%
FCF margin (%) 20.19% 10.52% 16.37% 16.93% 15.06% 14.05% 13.77% 15.14%
FCF / Net Income (%) 91.11% 56.85% 85.11% 87% 74.65% 79.17% 66.72% 70%

Profitability

        
ROA - 13.78% 14.32% - - - - -
ROE 25.77% 19.97% 19.19% 18.37% 18% 14.96% 17.59% 18%

Financial Health

        
Leverage (Debt/EBITDA) 0.03x - - - - - - -
Debt / Free cash flow 0.06x - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 14.91% 10.95% 12.63% 10.51% 11.36% 10.21% 10.6% 10.59%
CAPEX / EBITDA (%) 42.99% 35.3% 41.36% 34.76% 35.73% 35.07% 32.6% 31.67%
CAPEX / FCF (%) 73.85% 104.08% 77.12% 62.08% 75.48% 72.66% 76.96% 69.97%

Items per share

        
Cash flow per share 1 - - - - 8.407 8.3 9.5 10.5
Change - - - - - -1.28% 14.46% 10.53%
Dividend per Share 1 2 2 2.25 2.5 2.75 2.75 3.223 3.53
Change - 0% 12.5% 11.11% 10% 0% 17.21% 9.51%
Book Value Per Share 1 22.78 26.9 30.04 34.2 37.21 40.52 44.84 49.89
Change - 18.09% 11.67% 13.85% 8.8% 8.89% 10.66% 11.26%
EPS 1 5.25 4.96 5.46 5.9 6.42 5.819 7.514 8.52
Change - -5.52% 10.08% 8.06% 8.81% -9.36% 29.13% 13.39%
Nbr of stocks (in thousands) 23,852 23,852 23,852 23,852 23,852 23,852 23,852 23,852
Announcement Date 04/02/22 08/02/23 07/02/24 06/02/25 05/02/26 - - -
1SEK
Estimates
2026 *2027 *
P/E 28.5x 22.1x
PBR 4.1x 3.7x
EV / Sales 4.82x 4.24x
Yield 1.66% 1.94%

EPS & Dividend

EPS & Dividend - CellaVision AB


Y-o-Y evolution of P/E

Valuation ratios - P/E - CellaVision AB
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - CellaVision AB
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - CellaVision AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
166.00SEK
Average target price
181.67SEK
Spread / Average Target
+9.44%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CellaVision AB
  1. Stock Market
  2. Stocks
  3. CEVI Stock
  4. Financials CellaVision AB